Dr. Erin R. Alesi
Claim this profileVirginia Commonwealth University/Massey Cancer Center
Studies Cancer
Studies Squamous Cell Carcinoma
13 reported clinical trials
19 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
p16 positive
2Squamous Cell Carcinoma
Stage IV
Stage III
p16 negative
Affiliated Hospitals
Clinical Trials Erin R. Alesi is currently running
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
Brentuximab Vedotin + Pembrolizumab
for Advanced Cancers
This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer. There will be several different types of cancer studied in the trial. The cancer must have spread to other parts of the body (metastatic). The study will also find out what side effects occur. A side effect is anything the treatment does besides treat cancer. This is a multi-cohort study.
Recruiting1 award Phase 27 criteria
More about Erin R. Alesi
Clinical Trial Related4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Erin R. Alesi has experience with
- Pembrolizumab
- Cisplatin
- Carboplatin
- Nivolumab
- Intensity-Modulated Radiation Therapy
- Pemetrexed
Breakdown of trials Erin R. Alesi has run
Cancer
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erin R. Alesi specialize in?
Erin R. Alesi focuses on Cancer and Squamous Cell Carcinoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Erin R. Alesi currently recruiting for clinical trials?
Yes, Erin R. Alesi is currently recruiting for 5 clinical trials in Richmond Virginia. If you're interested in participating, you should apply.
Are there any treatments that Erin R. Alesi has studied deeply?
Yes, Erin R. Alesi has studied treatments such as Pembrolizumab, Cisplatin, Carboplatin.
What is the best way to schedule an appointment with Erin R. Alesi?
Apply for one of the trials that Erin R. Alesi is conducting.
What is the office address of Erin R. Alesi?
The office of Erin R. Alesi is located at: Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia 23298 United States. This is the address for their practice at the Virginia Commonwealth University/Massey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.